SCHEMBL17862618

SCHEMBL17862618

CC1(C)c2cc3cc(-c4ccc(-c5cccc(-c6ccccn6)n5)cc4)ccc3cc2-c2c1c1ccccc1c1ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CCR1 P32246 2/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ CCR8 P51685 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ ALPL P05186 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ ALPI P09923 1/20 0.38
▸ ALPG P10696 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TSHR P16473 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17862617 0.96 CCR1 (0.40) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862606 0.96 ABL1 (0.36) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862630 0.95 SMN1; SMN2 (0.38) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862629 0.92 SMN1; SMN2 (0.35) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862628 0.91 KDM4E (0.35) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862633 0.91 SMN1; SMN2 (0.38) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862619 0.87 CCR1 (0.32) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL20735871 0.85 PDK2 (0.38) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862960 0.85 MAPK1 (0.38) SMN1; SMN2CCR1CCR5CCR8KDM4E
SCHEMBL17862605 0.85 RARA (0.34) SMN1; SMN2DYRK1ARARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396288-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-08-27 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396288-B2 Organic electroluminescent element and electronic device RER1, LEF1, ELP1 SMN1; SMN2 2158/4885CCR1 128/4885CCR5 1627/4885
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RER1, LEF1, RPL18 SMN1; SMN2 2153/4885CCR1 130/4885CCR5 1629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback